Myriad Genetics' Supreme Court case frames the question of patents and genes in a way that's likely to hurt the life sciences industry, said patent lawyer Mercedes K. Meyer, an American Intellectual Property Law Association board member. "The headline is going to be, 'Human genes are not patentable.' Based on the nature of the question, that's what we expect the announcement to be," she said. The potential for a bad precedent was so great that "industry people went to Myriad and said just abandon the case, but they didn't listen to industry leaders," she said.

Related Summaries